Mark Louis Friedman
Direktor/Vorstandsmitglied bei BioFlorida, Inc.
Profil
Mark Louis Friedman is currently the Director at BioFlorida, Inc. He previously held positions as Vice President-Operations at AtriCure, Inc., Vice President-Quality & Regulatory at Enable Medical Corp., and VP-Regulatory Affairs & Quality Assurance at AxoGen Corp.
He also served as Vice President-Regulatory Affairs & Policy at Axogen, Inc. Dr. Friedman obtained a doctorate degree from the University of Cincinnati (Ohio) in 1986.
Aktive Positionen von Mark Louis Friedman
| Unternehmen | Position | Beginn |
|---|---|---|
BioFlorida, Inc.
 BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services BioFlorida, Inc. is an organization that represents the life science industry in Florida. The private company is based in Florida and represents over 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors, providing employment to 94,000 Floridians. The American company's initiatives aim to create a favorable business environment for the development of innovative products and technologies that enhance people's lives and bring economic benefits to the state. Nancy K. Bryan has been the CEO of the company since 2013. | Direktor/Vorstandsmitglied | 01.01.2021 |
Ehemalige bekannte Positionen von Mark Louis Friedman
| Unternehmen | Position | Ende |
|---|---|---|
| AXOGEN, INC. | General Counsel | 01.02.2022 |
AxoGen Corp.
 AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | General Counsel | 29.01.2014 |
| ATRICURE, INC. | Geschäftsführer | 01.01.2005 |
Enable Medical Corp.
 Enable Medical Corp. Medical SpecialtiesHealth Technology Enable Medical Corp. manufactures medical equipment for the treatment of bipolar patients. The company is based in West Chester, OH. D'Augustine. The company was founded by Norman R. Weldon, Michael D. Hooven, Rick J. Enable Medical was acquired by AtriCure, Inc. on August 10, 2005 for $7 million. | Corporate Officer/Principal | 01.01.2005 |
Enable Medical Corp.
Enable Medical Corp. Medical SpecialtiesHealth Technology Enable Medical Corp. manufactures medical equipment for the treatment of bipolar patients. The company is based in West Chester, OH. D'Augustine. The company was founded by Norman R. Weldon, Michael D. Hooven, Rick J. Enable Medical was acquired by AtriCure, Inc. on August 10, 2005 for $7 million. | Corporate Officer/Principal | 01.01.2001 |
Ausbildung von Mark Louis Friedman
| University of Cincinnati (Ohio) | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AXOGEN, INC. | Health Technology |
| ATRICURE, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | Health Technology |
Enable Medical Corp.
Enable Medical Corp. Medical SpecialtiesHealth Technology Enable Medical Corp. manufactures medical equipment for the treatment of bipolar patients. The company is based in West Chester, OH. D'Augustine. The company was founded by Norman R. Weldon, Michael D. Hooven, Rick J. Enable Medical was acquired by AtriCure, Inc. on August 10, 2005 for $7 million. | Health Technology |
BioFlorida, Inc.
BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services BioFlorida, Inc. is an organization that represents the life science industry in Florida. The private company is based in Florida and represents over 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors, providing employment to 94,000 Floridians. The American company's initiatives aim to create a favorable business environment for the development of innovative products and technologies that enhance people's lives and bring economic benefits to the state. Nancy K. Bryan has been the CEO of the company since 2013. | Commercial Services |